Coronavirus Update: Generics And Hurdles For Molnupiravir, More Japan Approvals
Plus, Valneva Promise Vs Omicron, CalciMedica Drug Progresses
More generic deals but also US approval hurdles for Merck's oral antiviral, while Japan approves more options and Valneva's vaccine candidate shows promise against Omicron.
